This trade activity should not be overlooked: Mereo Biopharma Group Plc ADR (MREO)

With 2.36 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.4 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.5497 whereas the lowest price it dropped to was $2.3301. The 52-week range on MREO shows […]

Mereo Biopharma Group Plc ADR (MREO) expanding its growth trajectory ahead

With 2.78 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.28 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.989 whereas the lowest price it dropped to was $1.72. The 52-week range on MREO shows […]

It makes sense and dollars to buy Mereo Biopharma Group Plc ADR (MREO) stock

With 1.35 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.24 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.27 whereas the lowest price it dropped to was $2.16. The 52-week range on MREO shows […]

A significant driver of top-line growth: Mereo Biopharma Group Plc ADR (MREO)

With 0.72 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.21 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.525 whereas the lowest price it dropped to was $2.38. The 52-week range on MREO shows […]

Its Stock Has Paid Off Big Time For Mereo Biopharma Group Plc ADR

With 1.64 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.14 million shares. The 52-week range on MREO shows that it touched its highest point at $5.02 and its lowest point at $2.37 during that stretch. It currently has a 1-year price target of $7.34. Beta for […]